Skip to main content
. Author manuscript; available in PMC: 2023 Aug 11.
Published in final edited form as: J Alzheimers Dis. 2020;78(2):721–734. doi: 10.3233/JAD-200132

Table 3.

Rate of Cognitive Change over Time from Baseline for Entire Cohort (N=114) and APOE4c (N=59) Subgrouped by BDNF Status

Total N=114 Total N=114 Total N=59
APOE4c (N=59) APOE4nc (N=55) P-Value BDNF Met Carrier (N=40) BDNF Val/Val (N=74) P-Value APOE4c/BDNF Met Carrier (N=20) APOE4c/BDNF Val/Val (N=39) P-Value APOE by BDNF P-Value
Time from Baseline, years Mean (SD) 15 (4.76) 15.04 (5.69) 0.97 13.93 (5.29) 15.61 (5.10) 0.10 13.4 (4.76) 15.82 (4.60) 0.06 0.62
FDG follow up time in years Mean (SD) 7.34 (3.60) N=50 8.56 (3.43) N=46 0.09 8.31 (3.52) N=32 7.73 (3.58) N=64 0.45 7.26 (3.99) N=17 7.38 (3.44) N=33 0.91 0.33
MMSE (SD) −0.03 (0.04) −0.01 (0.04) 0.06 −0.03 (0.04) −0.02 (0.04) 0.21 −0.04 (0.05) −0.02 (0.04) 0.10 0.28
AVLT TL (SD) −0.45 (0.55) −0.22 (0.48) 0.02* −0.31 (0.58) −0.36 (0.50) 0.64 −0.52 (0.75) −0.43 (0.44) 0.65 0.22
AVLT STM (SD) −0.14 (0.22) −0.04 (0.13) 0.01* −0.10 (0.19) −0.09 (0.18) 0.72 −0.17 (0.25) −0.12 (0.20) 0.43 0.13
AVLT LTM (SD) −0.17 (0.25) −0.06 (0.18) 0.01* −0.09 (0.21) −0.12 (0.23) 0.56 −0.15 (0.30) −0.17 (0.23) 0.86 0.08
COWAT (SD) 0.11 (0.46) 0.19 (0.50) 0.34 0.16 (0.47) 0.15 (0.49) 0.93 0.21 (0.61) 0.08 (0.41) 0.44 0.54
# of subjects who developed incident MCI 17 4 0.0004* 7 14 0.85 6 11 0.89 0.89

Table 3: Rate of cognitive change over time from baseline for entire cohort (N=114) and APOE4c (N=59) subgrouped by BDNF status was determined in the framework of linear mixed effects model for each subject who had at least two visits. Abbreviations: APOE4c: apolipoprotein e4 carrier, APOE4/4, 3/4; APOE4nc: apolipoprotein e4 non-carrier, APOE 3/3, 2/3; MMSE: Mini-Mental State Examination; AVLT: Auditory-Verbal Learning Test; STM: short term memory; LTM: long term memory; TL: total learning; COWAT: Controlled Oral Word Association Test. Note: COWAT tests executive function and language skills, on a scale with a lower limit of 0 and no upper limit, with higher scores indicating better performance. Data are given as mean +/‒ standard deviation unless otherwise indicated, p-values were computed under the linear mixed effect modeling with APOE4 and BDNF interaction term (p≤0.05)